Present-day approaches to pharmacotherapy – pharmaceutical care or drug management?

Česká verze

Authors: J. Kolář; B. Macešková
Authors place of work: Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav aplikované farmacie
Published in the journal: Čes. slov. Farm., 2010; 59, 7-10
Category: Přehledy a odborná sdělení

Summary

Optimization of pharmacotherapy has been traditionally contributed to by the physician, and in the concept of clinical pharmacy also by the pharmacist. As to the decision-making about pharmacotherapy, the idea of pharmaceutical care includes also the patient and as to the drug therapy management also the payer of the provided health care (health insurance companies). The terms pharmaceutical care and drug management are very close to each other but not identical, though they are often used as synonyms in the professional literature. The paper attempts to point out both the identical and different features of both concepts, the competence of individual categories of health workers in their execution, and the links to other terms used, such as the treatment of disease and the management of disease. It also points out to the differences in the understanding of these concepts in the European region and in the United States of America. It can be deduced from the found relationship between pharmaceutical care and drug therapy management that the concept of drug therapy management is superior to the concept of pharmaceutical care. It is desirable that both concepts blend with each other in some elements: the social viewpoint and the perspective of the patient should be added to pharmaceutical care and to the concept of drug management, respectively. Drug therapy management can be considered the strategy of how to incorporate the philosophy of pharmaceutical care into the everyday practice of pharmacies.

Key words:
pharmacotherapy – pharmaceutical care – drug management

Zdroje

1. Hepler, C. D., Strand, L. M.: Opportunities and responsibilities in pharmaceutical care. Amer. J. Hosp. Pharm., 1990; 47, 533–543.

2. Barber, N.: Pharmaceutical care and medicines management – is there a difference? Pharm. World Sci., 2001; 23, 210–211.

3. Strand, L. M., Cipolle, R. J., Morley, P. C.: Pharmaceutical care: an introduction. Kalamazoo, MI: Upjohn Company 1992, s. 14–29.

4. Kolář, J., Macešková, B., Ambrus, T.: K pojmům farmaceutická péče, lékárenská péče a správná lékárenská praxe. Čes. slov. Farm., 2009; 58, 55–59.

5. Bojar, M.: Rabelais by se divil – aneb o kvalitě života a farmakoterapii. http://www.lf2.cuni.cz/Projekty/ pelikan/peli1195/clanek09.htm?CZKODOVANI. (23. 2. 2009)

6. Rus, V.: Disease management – nadštandardná služba pre chronicky chorých pacientov. Med. Monitor 2007, č. 1, s. 11.

7. Armstrong, E. P., Langley, P. C.: Disease management programs. Amer. J. Health-Syst. Pharm., 1996; 53, 53–58.

8. Tweedie, A.: Managing patient therapy. Pharm. J., 1994; 252, 507–508.

9. APhA MTM Services Working Group: Medication Therapy Management Services Definition and Program Criteria 2004.

10. Welch, E. K., Delate, T., Chester, E. A., Stubbings, T.: Assessment of the impact of medication therapy management delivered to home–based Medicare beneficiaries. Ann. Pharmacother., 2009; 43, 603–610.

11. Pindolia, V. K., Stebelsky, L., Romain, T. M., Luoma, L., Nowak, S. N., Gillanders, F.: Mitigation of medication mishaps via medication therapy management. Ann. Pharmacother., 2009; 43, 611–620.

12. Pharmacy in the Future – Implementing the NHS Plan. A programme for pharmacy in the National Health Service. September 2000.

13. McGivney, M. S., Meyer, S. M., Duncan-Hewitt, W., Hall, D. L., Goode, J-V. R., Smith, R. B.: Medication therapy management: Its relationship to patient counseling, disease management, and pharmaceutical care. J. Amer. Pharm. Assoc., 2007; 47, 620–628.

14. A spoonful of sugar. Medicines management in NHS hospitals. www.audit-commission.gov.uk December 2001.

15. Burnett, K. M., Scott, M. G., Fleming, G. F., Clark, Ch. M., McElnay, J. C.: Effects of an integrated medicines management program on medication appropriateness in hospitalized patients. Amer. J. Health-Syst. Pharm., 2009; 66, 854–859.

16. Community pharmacy medicines management. A resource pack for community pharmacists. PSNC March 2005.

17. Hepler, Ch. D.: A promising way forward to the goal of systematic medicines management. Pharm. J., 2003; 271, 674.

18. Chapman, S. R.: The new pharmacy plan: how should the profession respond? Pharm. J., 2000; 265, 615–618.

19. Simpson, S.: What is medicines management and what is pharmaceutical care? Pharm. J., 2001; 266, 150.

20. Jenkins, D., Ghalamkari, H.: A pragmatic way forward. Pharm. J., 2001; 266, 281.

21. Tweedie, A., Jones, I.: What is medicines management? Pharm. J., 2001; 266, 248.

22. Tweedie, A.: Medicines management and change management – the PSNC pilot trials. Pharm. J., 2002; 268, 146.

23. Smith, L.: Medicines management strategy 2006–2009. Penine Care NHS Trust September 2006.

24. Oboh, L.: Pharmacists can help improve older people’s medicines management. Pharm. J., 2006; 276, 206–207.

25. Grindrod, K. A., Rosenthal, M., Lynd, L., Marra, C. A., Bougher, D., Wilgosh, Ch., Tsuyuki, R. T.: Pharmacists’ perspectives on providing chronic disease management services in the community – Part I: Current practice environment. Can. Pharm. J., 2009; 142, 234–239.

26. Rosenthal, M., Grindrod, K. A., Lynd, L., Marra, C. A., Bougher, D., Wilgosh, Ch., Tsuyuki, R. T.: Pharmacists’ perspectives on providing chronic disease management services in the community – Part II: Development and implementation of services. Can. Pharm. J., 2009; 142, 284–288.

27. Munroe, W. P., Kunz, K., Dalmady-Israel, Ch., Potter, L., Schonfeld, W. H.: Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin. Ther., 1997; 19, 113–123.

28. Anderson, W. K.: Pharmacists in the health care system. http://www.pharmacy.buffalo.edu/pprac_co_phcs. shtml (20. 12. 2009)

29. FIP Statement of policy the role of the pharmacist in the prevention and treatment of chronic disease. Approved by FIP Council in Brazil in August 2006.